Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people notice Mounjaro's appetite-suppressing effects within the first one to four weeks of starting treatment, though meaningful weight change typically becomes visible over the first eight to twelve weeks. The first dose begins acting within hours at a biochemical level, but the medicine's full effect builds gradually as your body adjusts to each new dose. Mounjaro (tirzepatide) is a prescription-only medicine; a prescriber assesses whether it is clinically suitable for you before any treatment begins. If you have just taken your first injection and are wondering whether anything is actually happening, you are not alone — that early waiting period can feel quietly frustrating.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You have done it: first pen, first dose. Nothing feels dramatic. That is normal, and it does not mean the medicine is not working.
Tirzepatide activates two gut-hormone receptors (GIP and GLP-1) both involved in appetite signalling and blood-sugar regulation. From the moment it enters your bloodstream, it starts slowing gastric emptying and signalling the brain that you are full sooner. Blood levels climb over the first 24 to 72 hours and stay elevated for the rest of the week. The how tirzepatide works page covers the dual-receptor mechanism in more detail if you want the science behind this.
At 2.5mg, the starter dose, the pharmacological effect is genuine but deliberately modest. The 2.5mg pen exists to let your digestive system adjust rather than to drive substantial weight loss on its own. Think of it as the body learning to tolerate the medicine. If you want a clear walkthrough of how to start taking Mounjaro, including what the first injection process looks like and what to prepare for, our dedicated page covers it step by step. The prescriber controls when you move to the next dose, that decision is not yours to make alone, and it should not be rushed.
If you are wondering how soon Mounjaro starts to work and what the early days typically look like, our dedicated page walks through the timeline in plain terms, including what counts as a normal start and what does not. Worth a read before you start.
This is the window most people find genuinely interesting, and sometimes confusing, because the changes do not always show up on the scales first.
Reduced hunger tends to arrive before measurable weight loss. You may find you stop thinking about food between meals, or that you leave food on the plate without trying. Some people describe it as the mental chatter around eating going quieter. For those who have spent years fighting appetite, that shift alone can feel significant.
Actual weight change follows as calorie intake drops consistently over days and weeks. Research from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that participants began losing meaningful weight from around week four onwards at therapeutic doses, with the curve steepening as doses increased. If you are curious about how quickly Mounjaro tends to work across different dose levels, we have covered that in more depth separately.
One thing worth knowing: individual timelines vary considerably. Factors including your starting weight, metabolic rate, diet during treatment, and how your body responds to tirzepatide all play a role. A slow start in weeks two and three does not indicate the medicine is failing you.
Mounjaro is titrated in steps: 2.5mg, then 5mg, then higher doses in 4-week intervals as the prescriber directs. Each increase often brings a fresh adjustment period.
When you move to a higher dose, some of the early side effects (mild nausea, early fullness, occasional digestive discomfort) can reappear briefly. This is the same settling-in process as the first week, just at a new baseline. It usually passes within a few days to two weeks. The what to expect after taking Mounjaro page goes into more detail on managing these transitions.
Progress in terms of weight loss typically accelerates after each dose increase, which is why the clinical trial results at 72 weeks look so much more substantial than the four-week snapshot. The full effect of Mounjaro (average body-weight reductions of around 20% in clinical trials at the highest dose) represents months of cumulative work, not a single injection's payoff. Our page on how soon Mounjaro starts working at each stage of the titration schedule explains what to realistically expect as doses increase over time.
If you are weighing up the cost of committing to this timeline, our treatment options page explains what is included at each stage and how pricing works transparently with no subscription.
Most people get through the early weeks without anything alarming. Mild nausea, occasional loose stools, or feeling full very quickly are expected and usually settle. You do not need to contact anyone for those.
You should speak to a prescriber or your GP if side effects are severe, persistent, or stopping you from eating or drinking properly. Dehydration from prolonged vomiting or diarrhoea deserves prompt attention, it can affect your kidneys if ignored.
Seek urgent medical help for severe, persistent abdominal pain that radiates to the back, with or without vomiting. The MHRA's January 2026 Drug Safety Update flagged acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines, it is rare, but that specific symptom pattern warrants immediate assessment, not a wait-and-see approach. Any suspected side effects can also be reported directly at the MHRA's Yellow Card scheme.
If you are not currently on Mounjaro and are thinking about starting, the first step is a clinical consultation. At nume, a GPhC-registered prescriber reviews your answers the same day, not a chatbot, a real clinician. Check your eligibility to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.